The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis
Authors:
Open Access
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (35) , 29968-29978
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaBMC Cancer, 2010
- Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor ProgressionJournal of Biological Chemistry, 2010
- MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer PatientsCancer Investigation, 2009
- Na+/H+ Exchangers and RhoA Regulate Acidic Extracellular pH‐Induced Lysosome Trafficking in Prostate Cancer CellsTraffic, 2009
- Prognostic Value of Tumor-Related Molecular Expression in Gastric CarcinomaPathology and Oncology Research, 2009
- Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer ProgressionClinical Cancer Research, 2008
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Novel Role for PDEF in Epithelial Cell Migration and InvasionCancer Research, 2005
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.1998